default author photo

Daniel Christ

Garvan Institute of Medical Research

384 VICTORIA STREET

Darlinghurst, New South Wales 2010

Australia

SCHOLARLY PAPERS

3

DOWNLOADS

311

TOTAL CITATIONS

4

Scholarly Papers (3)

1.

SARS-CoV-2 Omicron BA.5: Evolving Tropism and Evasion of Potent Humoral Responses and Resistance to Clinical Immunotherapeutics Relative to Viral Variants of Concern

Number of pages: 14 Posted: 11 Jul 2022
University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, Government of New South Wales - Virology Research Laboratory, University of New South Wales (UNSW) - Kirby Institute, Royal Melbourne Institute of Technology (RMIT University) - School of Health and Biomedical Sciences, Royal Melbourne Institute of Technology (RMIT University) - School of Health and Biomedical Sciences, CSL Behring AG - Department of Bioanalytical Sciences, CSL Behring AG - Department of Bioanalytical Sciences, CSL Behring AG - Department of Bioanalytical Sciences, Government of New South Wales - Serology and Virology Division (SAViD), Government of New South Wales - Virology Research Laboratory, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, St. Vincent's Hospital, Royal Melbourne Institute of Technology (RMIT University) - School of Health and Biomedical Sciences, St. Vincent's Hospital - Molecular Diagnostic Medicine Laboratory, Garvan Institute of Medical Research, University of New South Wales (UNSW) - Kirby Institute, Government of New South Wales - Virology Research Laboratory, University of New South Wales (UNSW) - Kirby Institute and University of New South Wales (UNSW) - Kirby Institute
Downloads 137 (534,155)
Citation 4

Abstract:

Loading...

SARS CoV2 Variants, immunotherapeutics, ACE2, TMPRSS2, Omicron

2.

Long-Term Persistence of Neutralizing Memory B Cells in SARS-CoV-2

Number of pages: 35 Posted: 25 Nov 2020
University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, Garvan Institute of Medical Research, Garvan Institute of Medical Research, Garvan Institute of Medical Research, University of Adelaide - Viral Immunology Group, Government of New South Wales - Virology Research Laboratory, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, The University of Sydney - School of Medical Sciences, Northern Beaches Hospital, University of New South Wales (UNSW) - Prince of Wales Clinical School, Royal North Shore Hospital, The University of Sydney - Westmead Hospital, The University of Sydney - Westmead Hospital, University of New South Wales (UNSW) - Kirby Institute, The University of Sydney - School of Medical Sciences, The University of Sydney - School of Medical Sciences, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute and Independent
Downloads 110 (640,165)

Abstract:

Loading...

SARS-CoV-2, neutralising antibodies, RBD, memory B cells

3.

Maintenance of Broad Neutralising Antibodies and Memory B Cells 12 Months Post-Infection Is Predicted by SARS-CoV-2 Specific CD4+ T Cell Responses

Number of pages: 54 Posted: 09 Sep 2021
University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, Garvan Institute of Medical Research, Garvan Institute of Medical Research, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - The Kirby Institute, University of Adelaide - Viral Immunology Group, Government of New South Wales - Virology Research Laboratory, University of New South Wales (UNSW) - Kirby Institute, affiliation not provided to SSRN, University of New South Wales (UNSW) - Kirby Institute, Northern Beaches Hospital, University of New South Wales (UNSW) - Prince of Wales Clinical School, Royal North Shore Hospital, The University of Sydney - Westmead Hospital, St George Hospital, Western Sydney University, The University of Sydney - Westmead Hospital, The University of Sydney, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute and University of New South Wales (UNSW) - Kirby Institute
Downloads 64 (924,743)

Abstract:

Loading...

SARS-CoV-2, 12 months after SARS-CoV-2 infection, RBD-specific memory B cells, protection efficacy prediction, SARS-CoV-2 antibodies, SARS-CoV-2 neutralisation, variants of concern, Delta variant